Fate Therapeutics Inc (FATE)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$1.04
Buy
$1.17
$0.03 (+2.88%)
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
Prices updated at 13 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Prices shown are in the currency of the stock selected. For example, if a UK stock is chosen these figures are in sterling, if a US stock chosen then the figures shown are in dollars.